Background: More than 761 million people rely on shared sanitation facilities. These have historically been excluded from international sanitation targets, regardless of the service level, due to concerns about acceptability, hygiene and access. In connection with a proposed change in such policy, we undertook this review to identify and summarize existing evidence that compares health outcomes associated with shared sanitation versus individual household latrines.
Methods And Findings: Shared sanitation included any type of facilities intended for the containment of human faeces and used by more than one household, but excluded public facilities. Health outcomes included diarrhoea, helminth infections, enteric fevers, other faecal-oral diseases, trachoma and adverse maternal or birth outcomes. Studies were included regardless of design, location, language or publication status. Studies were assessed for methodological quality using the STROBE guidelines. Twenty-two studies conducted in 21 countries met the inclusion criteria. Studies show a pattern of increased risk of adverse health outcomes associated with shared sanitation compared to individual household latrines. A meta-analysis of 12 studies reporting on diarrhoea found increased odds of disease associated with reliance on shared sanitation (odds ratio (OR) 1.44, 95% CI: 1.18-1.76).
Conclusion: Evidence to date does not support a change of existing policy of excluding shared sanitation from the definition of improved sanitation used in international monitoring and targets. However, such evidence is limited, does not adequately address likely confounding, and does not identify potentially important distinctions among types of shared facilities. As reliance on shared sanitation is increasing, further research is necessary to determine the circumstances, if any, under which shared sanitation can offer a safe, appropriate and acceptable alternative to individual household latrines.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990518 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0093300 | PLOS |
PLoS One
January 2025
Department of Human Anatomy, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Introduction: Limited or shared sanitation services are considered improved sanitation facilities, but they are shared between two or more households. Globally, 600 million people use shared toilet facilities. Although shared facilities are not classified as improved sanitation due to potential infection risks, inaccessibility, and safety concerns, this is a significant issue in developing countries like Ethiopia.
View Article and Find Full Text PDFChina CDC Wkly
January 2025
Center for Global Public Health, Chinese Center for Disease Control and Prevention, Beijing, China.
Since 2016, the Chinese Center for Disease Control and Prevention has continued to conduct project to assist Sierra Leone in improving its public health capacity and building a laboratory for bacteriological and parasitic diseases. Firstly, we can understand the epidemiological characteristics, etiological characteristics and drug resistance of important infectious diseases in Africa through this project, and provide services and guarantees for the construction of the Belt and Road Initiative. Secondly, the project is to carry out scientific research cooperation on the monitoring and detection capacity of major infectious diseases, biosecurity, and prevention and control technologies for important infectious diseases.
View Article and Find Full Text PDFPLoS One
January 2025
Business School, Shanghai Dianji University, Shanghai, Pudong, China.
This study investigates the behavioral choices of manufacturers, recyclers, and customers in Trade-In Programs designed to promote recycling and environmental sustainability. Using a manufacturer-led evolutionary game model, the research explores how factors such as government policies, market demand, financial incentives, and the simplicity of participation impact stakeholder engagement in these programs. Numerical simulations were conducted to analyze the effects of specific parameters on each participants' willingness to participate.
View Article and Find Full Text PDFPLoS One
January 2025
AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
BICSTaR (BICtegravir Single Tablet Regimen) is an ongoing, observational cohort study assessing the virologic effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in treatment-experienced (TE) and treatment-naïve (TN) people with HIV across 14 countries over 24 months. We present 12-month outcomes from participants in the BICSTaR Japan cohort. Retrospective and prospective data were pooled from people with HIV aged ≥20 years receiving B/F/TAF within routine clinical care in Japan.
View Article and Find Full Text PDFBMC Glob Public Health
January 2025
Department of Women and Children's Health, King's College London, London, UK.
Pre-eclampsia is a leading cause of maternal and neonatal mortality; 30,000 pre-eclampsia-related maternal deaths occur annually, with 70% in Sub-Saharan Africa (SSA) and 16% in South Asia. We have shown that early, accurate detection of hypertension combined with planned early delivery in women with late preterm pre-eclampsia significantly reduces stillbirth and severe maternal hypertension. We describe co-development and delivery of policy labs, working with The Policy Institute (King's College London), and local stakeholders in Sierra Leone and Zambia, to expedite integration of new knowledge into pre-eclampsia care pathways, to improve care for women and babies with the worst outcomes.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!